Cessatech is a Danish company active in the pharmaceutical industry. The company specializes in the research and development of analgesic nasal spray that is further used for the treatment of acute pain conditions among children. In addition to the main business, service and associated ancillary services are also offered. The business is run globally with the largest presence in the Nordic market.

Quotes for Cessatech A/S

Right Now

+/-
0.6
%
5,45%
Latest
11.6
High
12.8
Low
11.02
Volume
13 860
Turnover (DKK)
163 163
Value (MDKK)
42,7

Board

CEO

  • Jes Trygved

Chairperson of the Board

  • Adam Steensberg

Board

  • Charlotte Videbæk
  • Flemming Steen Jensen
  • Martin Olin
  • Peter Birk
  • Ulla Buhl

Largest Owners

Name Capital % Votes % Date
Jes Trygved 15,39 15,39 2021-12-08
Steen Winther Henneberg 13,59 13,59 2020-12-16
Bettina Nygaard Nielsen 13,59 13,59 2020-12-16
Buhl Krone Holding ApS 8,82 8,82 2021-12-08
C-Aps 1,12 1,12 2021-12-08
Martin Olin 1,07 1,07 2021-12-08
Adam Steensberg 0,73 0,73 2021-12-08
Peter Birk 0,17 0,17 2021-12-08
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-02-24 Bokslutskommuniké 2021

  • 2022-03-17 Årsstämma 2021